Trial Studied treatment Control Patients Size Study type Results NCT

Diabetes type 2 - glucose lowering for cardiovascular prevention in all type of patients

SUSTAIN 6, 2016semaglutideplacebo3297 (1648/1649) Exploratory NCT01720446